Home › NDC Lookup › Ingredients › Mineral Oil, Petrolatum, Phenylephrine H... › 45802-0188-16
🧴image loading
(from DailyMed)

Hemorrhoidal mineral oil, petrolatum, phenylephrine HCl 14 g/100g; 74.9 g/100g; .25 g/100g Ointment

by Padagis Israel Pharmaceuticals Ltd · 1 TUBE in 1 CARTON (45802-188-16) / 57 g in 1 TUBE
NDC 45802-0188-16
🏷️ FDA NDC (as labeled) 45802-188-16 billing pads the product segment with a zero
OTC On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 45802-188-16
Product NDC 45802-188
11-digit billing NDC 45802018816
NCPDP billing unit GM — per gram (weight)
RxCUI 1372298
UNII T5L8T28FGP, 4T6H12BN9U, 04JA59TNSJ
Application # M015
SPL Set ID 43826c68-0a20-460d-a7b5-f3e12395a7d0
Established class (EPC) alpha-1 Adrenergic Agonist
Mechanism of action Adrenergic alpha1-Agonists
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2013-11-01
Route RECTAL
Dosage form OINTMENT
Substance MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE
GPI-14 89994003224222
GPI class Hemorrhoidal
GCN Seq No 071294
GCN 35039
HICL code 039599
Ingredient (HICL) Phenyleph/Mineral Oil/Petrolat
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q3
Therapeutic class — intermediate (HIC2) Anal-Rectal Preparations
HIC3 code Q3D
Therapeutic class — specific (HIC3) Hemorrhoidal Preparations
AHFS code 12:12.04.00
AHFS class Alpha-Adrenergic Agonists (12:12)
FDB label name HEMORRHOIDAL OINTMENT
FDB brand name Hemorrhoidal Ointment
Legend status O — Over-the-counter (OTC) drug or device
Why two NDCs? The FDA registers this code as 45802-188-16 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 45802-0188-16. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Softeners, emollients class.

Drug family (ATC) Softeners, emollients
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerPadagis Israel Pharmaceuticals Ltd
FDA applicationM015 (OTC MONOGRAPH DRUG)
Labeler code45802
First marketedNov 2013
Product typeHuman Otc Drug
Portfolio175 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

Label name HEMORRHOIDAL OINTMENT Ingredient Phenyleph/Mineral Oil/Petrolat
🧪 What is this product?

This is an over-the-counter rectal ointment marketed under FDA's OTC monograph rules for hemorrhoidal products. It contains mineral oil and petrolatum, which function as lubricants and emollients to soften stool and ease discomfort, plus phenylephrine hydrochloride, a decongestant that is typically used to reduce swelling and shrink blood vessels in the affected area. The ointment is applied directly to the rectal area to address symptoms commonly associated with hemorrhoids.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 9E8X80D2L0
    A synthetic form of vitamin E used as an antioxidant and preservative in medications. It helps prevent the active ingredients from degrading when exposed to oxygen or light.
  • UNII 8SKN0B0MIM
    Benzoic acid is a naturally occurring organic acid used as a preservative in medicines and foods. It helps prevent bacterial and fungal growth to extend shelf life and maintain product stability.
  • UNII REK4960K2U
    Butylated hydroxyanisole is a synthetic preservative that prevents oils and fats in medicines from spoiling or becoming rancid. It keeps the medicine stable and extends its shelf life.
  • UNII 8470G57WFM
    Corn oil is a vegetable oil extracted from corn kernels. It's used in medicines as a solvent to dissolve active ingredients and help the body absorb them, and sometimes as a lubricant in capsules.
  • UNII PDC6A3C0OX
    Glycerin is a clear, thick liquid derived from plant oils or fats. It acts as a humectant to retain moisture, a sweetener, and a solvent in medications.
  • UNII 7EV65EAW6H
    Lanolin is a waxy substance derived from sheep's wool. It's used in medicines as an emollient and skin-conditioning agent to soften formulations and improve spreadability in topical products like creams and ointments.
  • UNII 884C3FA9HE
    Lanolin alcohol is a waxy substance derived from sheep's wool. It functions as an emollient and emulsifier in medicines, helping blend oil and water-based ingredients while softening the product's texture.
  • UNII A2I8C7HI9T
    Methylparaben is a preservative derived from benzoic acid that prevents growth of bacteria, fungi, and mold in medicines. It extends the product's shelf life and maintains safety during storage.
  • UNII I9O0E3H2ZE
    Paraffin is a waxy, petroleum-derived substance used as a coating, lubricant, and hardening agent in tablets and capsules. It helps protect the medicine from moisture and gives pills a smooth finish.
  • UNII Z8IX2SC1OH
    Propylparaben is a chemical preservative used to prevent bacterial and fungal growth in medicines and personal care products. It helps extend shelf life and maintain product safety during storage.
  • UNII 2UK410MY6B
    Thyme oil is an essential oil extracted from the thyme plant. It's used in medicines as a flavoring agent and preservative to improve taste and help maintain product stability.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
  • UNII 7G1J5DA97F
    White wax is a refined, bleached plant-based or mineral wax that serves as a coating and hardening agent in medicines. It helps control how fast the drug dissolves and improves the product's texture and appearance.

13 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesbenzoic acid, butylated hydroxyanisole, corn oil, glycerin, lanolin, lanolin alcohols, methylparaben, mineral oil, paraffin, propylparaben, purified water, thymus vulgaris (thyme) oil, tocopheryl acetate, white wax

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly $0.057 $3.25 / 57 g
Medicaid paysCMS SDUD · 12 mo $0.1496 $8.53 / 57 g
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per g) — tap or hover for the price & month
Dec 2021 Aug 2022 Jan 2026 Sep 2026 $0.057 $0.041
▲ Up 36% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Good Sense Hemorrhoidal 14 g/100g; 74.9 g/100g; .25 g/100g 00113-0188-16 L. 1 tube $0.057 — Availability likely —
Hemorrhoidal .25 g/100g; 14 g/100g; 74.9 g/100g 00536-1288-06 Rugby 1 tube $0.057 — Availability likely —
Hemorrhoidal 14 g/100g; 74.9 g/100g; .25 g/100gthis 45802-0188-16 Padagis 1 tube $0.057 — Availability likely —
GNP Hemorrhoidal 2.5 mg/g; 749 mg/g; 140 mg/g 46122-0677-46 Amerisource 1 tube $0.057 — Availability likely —
Hemorrhoidal .25 g/100g; 14 g/100g; 74.9 g/100g 70000-0046-01 Cardinal 1 tube $0.057 — Availability likely —
foster and thrive hemorrhoidal 14 g/100g; 74.9 g/100g; .25 g/100g 70677-1108-01 Strategic 1 tube $0.057 — Availability likely —
Walgreens 2.5 mg/g; 140 mg/g; 749 mg/g 00363-6503-01 Walgreens 1 tube — — FDA listed —
Hemorrhoidal Pain Relief 2.5 mg/g; 140 mg/g; 749 mg/g 00363-9876-02 WALGREENS 1 tube — — FDA listed —
Preparation H 2.5 mg/g; 140 mg/g; 749 mg/g 00573-2871-04 Haleon 1 tube — — FDA listed —
Hemorrhoidal 14 g/100g; 74.9 g/100g; .25 g/100g 11822-0006-00 Rite 1 tube — — Discontinued —
Hemorrhoidal 2.5 mg/g; 749 mg/g; 140 mg/g 13709-0319-01 NeilMed 1 tube — — FDA listed —
Hemorrhoidal Pain Relief 749 mg/g; 140 mg/g; 2.5 mg/g 13709-0334-01 Neilmed 1 tube — — FDA listed —
signature care hemorrhoidal 14 g/100g; 74.9 g/100g; .25 g/100g 21130-0577-16 Safeway 1 tube — — FDA listed —
Hemorrhoidal 14 g/100g; 74.9 g/100g; .25 g/100g 21130-0687-16 Safeway 1 tube — — FDA listed —
Signature Care Hemorrhoidal 749 mg/g; 2.5 mg/g; 140 mg/g 21130-0789-14 Better 1 tube — — FDA listed —
Hemorrhoidal 14 g/100g; 74.9 g/100g; .25 g/100g 30142-0188-16 Kroger 1 tube — — FDA listed —
topcare hemorrhoidal 14 g/100g; 74.9 g/100g; .25 g/100g 36800-0499-16 Topco 1 tube — — FDA listed —
Equaline Hemorrhoidal 14 g/100g; 74.9 g/100g; .25 g/100g 41163-0188-16 United 1 tube — — FDA listed —
hemorrhoidal 14 g/100g; 74.9 g/100g; .25 g/100g 41250-0188-16 Meijer 1 tube — — FDA listed —
careone hemorrhoidal 14 g/100g; 74.9 g/100g; .25 g/100g 41520-0188-16 American 1 tube — — FDA listed —
0.25 % PHENYLEPHRINE HCl HEMORRHOIDAL 14 g/100g; 74.9 g/100g; .25 g/100g 43473-0094-02 Nantong 1 tube — — FDA listed —
Equate Hemorrhoidal 14 g/100g; 74.9 g/100g; .25 g/100g 49035-0188-16 Wal-Mart 1 tube — — FDA listed —
Hemorrhoidal 140 mg/g; 749 mg/g; 2.5 mg/g 51316-0228-01 CVS 1 tube — — FDA listed —
CAREALL Hemorrhoidal 140 mg/g; 749 mg/g; 2.5 mg/g 51824-0079-02 New 56 g — — FDA listed —
Hemorrhoid Anesthetic .14 g/g; .749 g/g; .0025 g/g 52000-0057-01 Universal 1 tube — — Discontinued —
0.25 % PHENYLEPHRINE HCl HEMORRHOIDAL 14 g/100g; 74.9 g/100g; .25 g/100g 52000-0438-02 Universal 1 tube — — FDA listed —
Exchange Select Hemorrhoidal 14 g/100g; 74.9 g/100g; .25 g/100g 55301-0188-16 Army 1 tube — — FDA listed —
Family Wellness Hemorrhoidal 749 mg/g; 140 mg/g; 2.5 mg/g 55319-0381-56 Family 1 tube — — FDA listed —
TheraPlus Plus .25 g/100g; 14 g/100g; 74.9 g/100g 55621-0005-01 Zhejiang 42 g — — FDA listed —
Family Wellness .25 g/100g; 14 g/100g; 74.9 g/100g 55621-0006-01 Zhejiang 1 tube — — FDA listed —
ProCure Hemorrhoidal 74.9 g/100g; .25 g/100g; 14 g/100g 55681-0021-02 Twin 56.6 g — — FDA listed —
DG Health Hemorrhoidal 14 g/100g; 74.9 g/100g; .25 g/100g 55910-0188-16 Dolgencorp, 1 tube — — FDA listed —
Hemorrhoidal 14 g/100g; 74.9 g/100g; .25 g/100g 56062-0188-16 Publix 1 tube — — FDA listed —
Hemorrhoidal 14 g/100g; 74.9 g/100g; .25 g/100g 63187-0505-02 Proficient 1 tube — — FDA listed —
HemorrhoidalOintment 14 g/100g; 74.9 g/100g; .25 g/100g 68016-0528-00 Pharmacy 1 tube — — FDA listed —
HemorrhoidalOintment 14 g/100g; 74.9 g/100g; .25 g/100g 69396-0020-01 Trifecta 1 tube — — FDA listed —
HemorrhoidalOintment 14 g/100g; 74.9 g/100g; .25 g/100g 69396-0082-02 Trifecta 1 tube — — FDA listed —
HemorrhoidalOintment 74.9 g/100g; .25 g/100g; 14 g/100g 69396-0083-01 Trifecta 1 tube — — FDA listed —
HemorrhoidalOintment 14 g/100g; 74.9 g/100g; .25 g/100g 69396-0133-20 Trifecta 1 tube — — FDA listed —
hemorrhoidal 749 mg/g; 2.5 mg/g; 140 mg/g 69452-0448-38 Bionpharma 1 tube — — FDA listed —
Family wellness 14 g/100g; 74.9 g/100g; .25 g/100g 69571-0006-02 FRONT 1 tube — — FDA listed —
TheraCare Hemorrhoidal 14 g/100g; 74.9 g/100g; .25 g/100g 71101-0935-01 Veridian 1 tube — — FDA listed —
Hemorrhoidal 14 g/100g; 74.9 g/100g; .25 g/100g 72162-2282-02 Bryant 1 tube — — FDA listed —
Basic Care Hemorrhoidal 14 g/100g; 74.9 g/100g; .25 g/100g 72288-0188-16 Amazon.com 1 tube — — FDA listed —
Hemorrhoidal .25 g/100g; 14 g/100g; 74.9 g/100g 83324-0045-02 Chain 1 tube — — FDA listed —
Hemorrhoidal 14 g/100g; 74.9 g/100g; .25 g/100g 85766-0140-57 Sportpharm 1 tube — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2013
On the market since
Nov 2013
📍
2026
Currently FDA-listed
13 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🗺️ Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 45802-0188-16, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
461
Units reimbursed last 4 qtrs
27.3K
Gross reimbursed last 4 qtrs
$4.1K
Avg / prescription
$8.86
Avg / unit
$0.1496
Latest quarter Q1 2026
122Rx
Medicaid pays / g
$0.1496
gross reimbursed
vs
NADAC / g
$0.0571
acquisition cost
=
Spread
+$0.0925
+162% vs cost
What Medicaid paid per g (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
19% FFS 81% MCO
Fee-for-service · 87 Rx Managed care · 374 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 1,881 units · 32.8 per 100k residents MN Wisconsin: no data reported WI Michigan: no data reported MI New York: no data reported NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: 3,048 units · 95.4 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: 3,817 units · 55.6 per 100k residents IN Ohio: 11,798 units · 100 per 100k residents OH Pennsylvania: no data reported PA New Jersey: 1,539 units · 16.6 per 100k residents NJ Massachusetts: no data reported MA California: no data reported CA Utah: no data reported UT Colorado: no data reported CO Nebraska: 4,587 units · 232 per 100k residents NE Missouri: no data reported MO Kentucky: no data reported KY West Virginia: no data reported WV Virginia: 627 units · 7.2 per 100k residents VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
7.2232
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Nebraska 232 /100k
2 Ohio 100 /100k
3 Nevada 95.4 /100k
4 Indiana 55.6 /100k
5 Minnesota 32.8 /100k
6 New Jersey 16.6 /100k
7 Virginia 7.2 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Hemorrhoidal (this brand).

Top reported reactions

Pain11
Dyspnoea7
Nausea7
Fatigue6
Constipation5
Death5
Pneumonia5

Age at onset

Adult6
Elderly6

Reporter sex

73 reports
Male · 44%
Female · 56%

Serious outcomes

Hospitalization17
Life-threatening4
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 4 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
45802-0188-16 You're viewing this 1 TUBE in 1 CARTON (45802-188-16) / 57 g in 1 TUBE 2013-11-01 Active

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 45 words ▾

Uses • helps relieve the local itching and discomfort associated with hemorrhoids • temporarily shrinks hemorrhoidal tissue and relieves burning • temporarily provides a coating for relief of anorectal discomforts • temporarily protects the inflamed, irritated anorectal surface to help make bowel movements less painful

⏱️ Dosage and Administration 127 words ▾

Directions • adults: when practical, cleanse the affected area by patting or blotting with an appropriate cleansing wipe. Gently dry by patting or blotting with a tissue or a soft cloth before applying ointment. • when first opening the tube, puncture foil seal with top end of cap • apply to the affected area up to 4 times daily, especially at night, in the morning or after each bowel movement • intrarectal use: remove cover from applicator, attach applicator to tube, lubricate applicator well and gently insert applicator into the rectum, thoroughly cleanse applicator after each use and replace cover • also apply ointment to external area • regular use provides continual therapy for relief of symptoms • children under 12 years of age: ask a doctor

⚠️ Warnings 135 words ▾

Warnings For external and/or intrarectal use only Ask a doctor before use if you have • heart disease • high blood pressure • diabetes • thyroid disease • difficulty in urination due to enlargement of the prostate gland Ask a doctor or pharmacist before use if you are presently taking a prescription drug for high blood pressure or depression. When using this product do not exceed the recommended daily dosage unless directed by a doctor Stop use and ask a doctor if • bleeding occurs • condition worsens or does not improve within 7 days • introduction of applicator into the rectum causes additional pain If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

📦 Storage and Handling 7 words ▾

Other information • store at 20-25°C (68-77°F)

🧪 Active Ingredient 10 words ▾

Active ingredients Mineral oil 14% Petrolatum 74.9% Phenylephrine HCl 0.25%

🧪 Inactive Ingredients 27 words ▾

Inactive ingredients benzoic acid, butylated hydroxyanisole, corn oil, glycerin, lanolin, lanolin alcohols, methylparaben, mineral oil, paraffin, propylparaben, purified water, thymus vulgaris (thyme) oil, tocopheryl acetate, white wax

🎯 Purpose 3 words ▾

Purposes Protectant Vasoconstrictor

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 45802-0169-72 · Padagis 45802-0201-26 · Padagis →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.